C3ORF26 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.109800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.302400E-02
Normal-vs-Stage2
4.176600E-01
Normal-vs-Stage3
4.159800E-01
Normal-vs-Stage4
2.006800E-01
Stage1-vs-Stage2
5.854600E-01
Stage1-vs-Stage3
8.363400E-01
Stage1-vs-Stage4
6.109600E-01
Stage2-vs-Stage3
8.023400E-01
Stage2-vs-Stage4
8.640600E-01
Stage3-vs-Stage4
9.425200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.914400E-01
Normal-vs-AfricanAmerican
2.769600E-01
Normal-vs-Asian
8.417600E-01
Caucasian-vs-AfricanAmerican
7.981200E-01
Caucasian-vs-Asian
5.960400E-03
AfricanAmerican-vs-Asian
5.067700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.546600E-01
Normal-vs-Female
3.403400E-01
Male-vs-Female
9.876600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.968400E-01
Normal-vs-Age(41-60Yrs)
2.579600E-01
Normal-vs-Age(61-80Yrs)
5.192600E-01
Normal-vs-Age(81-100Yrs)
2.387400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.170800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.980000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.899000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.633410E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.542600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.471200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.684000E-01
Normal-vs-Daily Drinker
3.459000E-01
Normal-vs-Weekly Drinker
4.583200E-01
Normal-vs-Occasional Drinker
4.718200E-01
Normal-vs-Social Drinker
4.616400E-01
Non Drinker-vs-Daily Drinker
4.700800E-01
Non Drinker-vs-Weekly Drinker
3.560800E-01
Non Drinker-vs-Occasional Drinker
2.832800E-01
Non Drinker-vs-Social Drinker
7.555400E-01
Daily Drinker-vs-Weekly Drinker
7.248600E-01
Daily Drinker-vs-Occasional Drinker
4.772200E-01
Daily Drinker-vs-Social Drinker
7.493200E-01
Weekly Drinker-vs-Occasional Drinker
7.381400E-01
Weekly Drinker-vs-Social Drinker
5.792400E-01
Occasional Drinker-vs-Social Drinker
3.877800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.307600E-01
Normal-vs-Grade 2
7.810400E-01
Normal-vs-Grade 3
8.189000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.453620E-01
Grade 1-vs-Grade 3
9.548200E-02
Grade 1-vs-Grade 4
7.307600E-01
Grade 2-vs-Grade 3
4.300400E-01
Grade 2-vs-Grade 4
7.810400E-01
Grade 3-vs-Grade 4
8.189000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.549000E-01
Normal-vs-NonDiabetic
3.812000E-01
Diabetic-vs-NonDiabetic
9.439800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.374200E-01
Normal-vs-NoPancreatitis
4.321800E-01
Pancreatitis-vs-NoPancreatitis
3.800800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.032000E-01
Normal-vs-N1
3.787400E-01
N0-vs-N1
3.932600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.423400E-01
Normal-vs-TP53-NonMutant
5.122600E-01
TP53-Mutant-vs-TP53-NonMutant
1.438330E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
